Senior insider sale
MAZE THERAPEUTICS, INC. — senior position signals high conviction
$984.6K
27.50K shares
What this filing means
KATHIRESAN SEKAR plans to sell 27.50K shares of MAZE THERAPEUTICS, INC. valued at approximately $984.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/21/2025ACC: 0001950047-25-009187
27.50K
Shares to sell
$984.6K
Approx. market value
27.50K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Founder Stock
Cash
11/1/2018
27.50KTotal acquired27.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/1/2018 | Founder Stock Cash | 27.50K | — |
| Total | 27.50K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
27.50K
Market value
$984.6K
11/21/2025
Total
Units
27.50K
Value
$984.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
11/21/2025 | 27.50K | $984.6K | NASDAQ | Planned |
| Total | 27.50K | $984.6K | ||